NCT00026260View on ClinicalTrials.gov

SU5416 in Treating Patients With Persistent or Recurrent Cervical Cancer

PHASE2CompletedINTERVENTIONAL

Timeline

Start Date

Not specified

Study Completion Date

October 31, 2003

Conditions

Cervical Cancer

Interventions

DRUG

semaxanib

All Listed Sponsors

collaborator

National Cancer Institute (NCI)

NIH

lead

Gynecologic Oncology Group

NETWORK

NCT00026260 - SU5416 in Treating Patients With Persistent or Recurrent Cervical Cancer | Biotech Hunter | Biotech Hunter